Cyperguard Concentrate for Dip Emulsion

Страна: Ірландія

мова: англійська

Джерело: HPRA (Health Products Regulatory Authority)

Активний інгредієнт:

Cypermethrin (Cis:Trans 80:20)

Доступна з:

Bimeda Animal Health Limited

Код атс:

QP53AC08

ІПН (Міжнародна Ім'я):

Cypermethrin (Cis:Trans 80:20)

Дозування:

10 percent weight/weight

Фармацевтична форма:

Concentrate for dip emulsion

Тип рецепту:

POM: Prescription Only Medicine as defined in relevant national legislation

Терапевтична области:

cypermethrin

Статус Авторизація:

Authorised

Дата Авторизація:

1998-05-15

Характеристики продукта

ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cyperguard Concentrate for Dip Emulsion
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Cypermethrin High Cis (80/20)
100 mg/g
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS
N-methyl 2 pyrrolidone
N-octyl 2 pyrrolidone
Ethoxylated Castor Oil
Pluronic L31
Rhodafac RS 710
A clear, pale yellow liquid.
3. CLINICAL INFORMATION
3.1 TARGET SPECIES
Sheep.
3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES
For the prevention and treatment of blowfly strike, lice, keds and
ticks on sheep by plunge dipping after
dilution of the product with water. For the prevention and treatment
of sheep scab caused by pyrethroid
sensitive mites.
3.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
3.4 SPECIAL WARNINGS
Sheep should never be dipped on a full stomach, when the wool is wet
or when they are heated, tired,
thirsty or suffering from wounds or open sores.
Choose a cool dry day and dip early in the morning.
Rest sheep 2 or 3 hours before dipping.
Rams and fat sheep should be assisted through the baths and lambs
dipped separately from the ewes.
Care should be taken to ensure that the sheep do not swallow or inhale
any wash.
Unnecessary use of antiparasitics or use deviating from the
instructions given in the SPC may increase the
resistance selection pressure and lead to reduced efficacy. The
decision to use the product should be based
on confirmation of the parasitic species and burden, or of the risk of
infestation based on its
epidemiological features, for each individual animal or flock.
The use of this product should take into account local information
about susceptibility of the target
parasites, where available.
It is recommended to further investigate cases of suspected
resistance, using an appropriate diagnostic
method.
Confirmed resistance should be reported to the marketing authorisation
holder or to the competent
authori